tiprankstipranks
CNBX Pharmaceuticals (CNBX)
OTHER OTC:CNBX
US Market
CNBX
CNBX Pharmaceuticals
RESEARCH TOOLSreports
Want to see CNBX full AI Analyst Report?

CNBX Pharmaceuticals (CNBX) Income Statement

122 Followers

CNBX Pharmaceuticals Income Statement

Last quarter (Q2 2026), CNBX Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, CNBX Pharmaceuticals's net income was $-44.10K. See CNBX Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Aug 25Aug 24Aug 23Aug 22Aug 21
Total Revenue
$ 0.00$ 130.07K$ 410.17K$ 29.96K$ 0.00
Gross Profit
$ 0.00$ 130.07K$ 410.17K$ -169.00K$ -221.00K
Operating Expenses
$ 271.69K$ 713.21K$ 1.34M$ 2.79M$ 2.60M
Depreciation and Amortization
$ 0.00$ 72.32K$ 162.06K$ 198.53K$ 220.93K
EBITDA
$ -273.79K$ -603.00K$ -3.55M$ -3.52M$ -2.91M
Operating Income
$ -271.69K$ -583.00K$ -931.00K$ -2.95M$ -2.60M
Other Income/Expenses
$ -42.28K$ -112.00K$ -2.78M$ -1.39M$ -594.00K
Pretax Income
$ -313.98K$ -695.00K$ -3.71M$ -4.35M$ -3.19M
Net Income
$ -313.98K$ -695.00K$ -3.71M$ -3.72M$ -3.19M
Per Share Metrics
Basic EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Diluted EPS
$ 0.00$ -0.02$ -0.42$ -3.59$ -2.16
Weighted Average Shares Outstanding
 90.65M 30.25M 8.82M 1.22M 1.15M
Weighted Average Shares Outstanding (Diluted)
 90.65M 30.25M 8.82M 1.22M 1.15M
Currency in USD

CNBX Pharmaceuticals Earnings and Revenue History